17:34 , Jan 9, 2019 |  BC Innovations  |  Distillery Therapeutics

Endocrine/metabolic

INDICATION: Metabolic Mouse studies suggest inhibiting SGLT2 could help treat G6PC3 deficiency-induced neutropenia. In a mouse model of G6PC3 deficiency, the SGLT2 inhibitor Jardiance empagliflozin decreased granulocyte maturation arrest in the bone marrow and increased...